NIM
ALNA

Needham Investment Management’s Allena Pharmaceuticals ALNA Stock Holding History

Needham Investment Management’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,616
Closed -$200K – 88
2018
Q3 		$200K Buy
+4,616
New +$50.7K 0.06% 81
2018
Q2 		– Sell
-18,288
Closed -$310K – 99
2018
Q1 		$310K Hold
18,288
– – 0.09% 84
2017
Q4 		$259K Buy
+18,288
New +$225K 0.07% 85

Other funds holding ALNA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Needham Investment Management's ALNA Position: Q4 2018 in Review

Needham Investment Management sold out of Allena Pharmaceuticals (ALNA) in Q4 2018, closing a stake of 4,616 shares — an estimated $200K sold.

Needham Investment Management first reported a position in ALNA in Q4 2017 and held it in 3 quarters. The position peaked at $310K in Q1 2018. 49 funds tracked by Wall St. Rank hold ALNA as of Q4 2018.

  • Needham Investment Management reported no remaining Allena Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Needham Investment Management sold 4,616 Allena Pharmaceuticals shares in Q4 2018, an estimated $200K.
  • Needham Investment Management first reported a position in Allena Pharmaceuticals in Q4 2017 and held it in 3 quarters.
  • Needham Investment Management's Allena Pharmaceuticals position peaked at $310K in Q1 2018.
  • 49 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q4 2018.

Based on Needham Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.